Liver Transplant Technique for Colorectal Cancer
(CLEAR Trial)
Trial Summary
What is the purpose of this trial?
Liver transplantation (LT) has become an accepted treatment for selected patients with unresectable liver metastases due to colorectal cancer (CRLM). The goal of this study is to look at and compare the clinical results of all the different approved methods (living vs. Deceased, whole organ vs. Split, one staged vs. Two staged) used to perform a standard liver transplant procedure for recipients with CRLM. Investigators will look at things like different procedure results, recovery in the hospital, and survival rates one year after the transplant. Investigators will also take blood samples from participants to be used in future research. All the transplant methods the investigators are comparing are standard practices approved by the United Network of Organ Sharing (UNOS).
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Resection And Partial Liver Transplantation With Delayed Total Hepatectomy for colorectal cancer?
Research shows that patients with colorectal cancer that has spread to the liver can live longer with surgical treatments like partial liver removal or liver transplantation. Studies indicate that these approaches can improve survival compared to just using chemotherapy, especially when the cancer cannot be fully removed by surgery alone.12345
Is the RAPID liver transplant technique safe for humans?
How is the RAPID treatment for colorectal cancer different from other treatments?
The RAPID treatment is unique because it involves a two-step liver transplant process where a small part of the liver is transplanted first, followed by the complete removal of the liver later. This approach aims to expand the donor pool and is still experimental, primarily used in clinical trials for patients with non-resectable liver tumors.48101112
Eligibility Criteria
This trial is for patients with colorectal cancer that has spread to the liver and cannot be removed with surgery alone. Candidates must not have had previous liver transplants or other treatments that would exclude them from a partial transplant followed by delayed total hepatectomy.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Transplantation
Participants undergo liver transplantation using various approved methods (living vs. deceased, whole organ vs. split, one staged vs. two staged)
Follow-up
Participants are monitored for graft and patient survival outcomes, as well as complications or surgical outcomes
Treatment Details
Interventions
- Resection And Partial Liver Transplantation With Delayed Total Hepatectomy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor